本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

INVION LTD

0.110
-0.005-4.35%
成交量:5.13万
成交额:5,435.00
市值:933.63万
市盈率:-1.04
高:0.110
开:0.110
低:0.105
收:0.115
数据加载中...

公司资料

公司名字:
INVION LTD
交易所:
ASX
成立时间:
2000
员工人数:
4
公司地址:
100 Albert Road,Level 4,Melbourne,Victoria,Australia
邮编:
3205
传真:
- -
简介:
Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.